JETEMA, Co., Ltd. (KOSDAQ:216080)
South Korea · Delayed Price · Currency is KRW 6,490.00
-100.00 (-1.52%)
Aug 14, 2025, 3:30 PM KST
JETEMA, Market Cap
JETEMA, has a market cap or net worth of 232.72 billion as of August 15, 2025. Its market cap has decreased by -19.46% in one year.
Market Cap
232.72B
Enterprise Value
333.61B
Revenue
67.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,490.00
Market Cap Chart
Since November 14, 2019, JETEMA,'s market cap has increased from 129.11B to 232.72B, an increase of 80.25%. That is a compound annual growth rate of 10.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 232.72B | -16.08% |
| Dec 30, 2024 | 277.33B | -0.13% |
| Dec 28, 2023 | 277.70B | 19.01% |
| Dec 29, 2022 | 233.35B | -35.77% |
| Dec 30, 2021 | 363.31B | -9.68% |
| Dec 30, 2020 | 402.27B | 139.94% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.52T |
| Celltrion | 38.80T |
| ALTEOGEN | 23.35T |
| Yuhan | 8,487.38B |
| Peptron | 8,130.78B |
| SK Biopharmaceuticals | 7,846.99B |
| PharmaResearch | 6,909.12B |
| LigaChem Biosciences | 5,648.08B |